T1	Participants 43 80	patients without erosive oesophagitis
T2	Participants 94 234	Patients with chronic heartburn but with no endoscopic evidence of erosive oesophagitis require gastric acid suppression to relieve symptoms
T3	Participants 526 584	40 mg (n = 241) or 20 mg (n = 234), with placebo (n = 242)
T4	Participants 1598 1635	patients without erosive oesophagitis
